New Evidence on Metabolic Benefits of Lacticaseibacillus paracasei NB۲۳

آخرین بروزرسانی :

فهرست مطالب

A new randomized controlled trial published in Probiotics and Antimicrobial Proteins (2025) reports that daily supplementation with Lacticaseibacillus paracasei NB23 significantly improves metabolic health, muscle mass, and lower-limb strength in healthy adults.

The 12-week study involving 51 participants showed that NB23 increased muscle mass, leg strength, and IGF-1 levels, while improving key cardiometabolic markers including blood pressure, lipid profile, insulin resistance (HOMA-IR), and inflammatory cytokines.

Researchers from Hungkuang University and Kuang-Tien General Hospital (Taiwan) highlighted that the beneficial effects of NB23 can be categorized into three main domains: enhanced metabolic health, improved muscle strength and mass, and activation of IGF-1 signaling pathways

IGF-1 plays a central role in muscle growth, repair, and function, while also supporting insulin sensitivity and preventing sarcopenia. The observed improvements in blood pressure and lipid markers further suggest potential cardiovascular benefits.

The study supports previous evidence on the role of L. paracasei strains in promoting muscle function, cardiometabolic resilience, and gut microbiota balance, making NB23 a promising candidate as a functional food ingredient.

Reference:

Lin, S., Ko, WS., Kuo, FC. et al. The Effects of Lactobacillus paracasei NB23 on IGF-1, Muscle Function, and Cardiometabolic Risk Factors in Healthy Individuals: A Randomized Controlled Trial. Probiotics & Antimicro. Prot. (2025). https://doi.org/10.1007/s12602-025-10604-4

Leave a Reply

Your email address will not be published. Required fields are marked *